SCHEMBL6896766

SCHEMBL6896766

COc1cc(C(=O)c2ccc(Br)cc2)ccc1OC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
TSHR P16473 1/20 0.54
CYP2C19 P33261 1/20 0.54
PDE4B Q07343 11/20 0.53
PDE4D Q08499 11/20 0.53
PDE4A P27815 9/20 0.53
PDE4C Q08493 9/20 0.53
MAPK14 Q16539 1/20 0.53
KMT2A Q03164 1/20 0.52
ALDH1A1 P00352 2/20 0.51
GAA P10253 1/20 0.51
PDE5A O76074 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6881789 0.95 PDE4D (0.60) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL27472680 0.86 PDE4D (0.68) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL31148879 0.83 CYP1A2 (0.79) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL1009826 0.83 CYP1A2 (0.79) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL7909156 0.83 PDE4B (0.61) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL4162765 0.83 PDE5A (0.70) PDE4BPDE4DPDE4APDE4CMAPK14
SCHEMBL7910791 0.83 ALDH1A1 (0.68) PDE4BPDE4DPDE4APDE4CMAPK14
SCHEMBL6799815 0.82 PDE4B (0.71) TSHRPDE4BPDE4DPDE4APDE4C
SCHEMBL7384113 0.82 PDE4B (0.62) PDE4BPDE4DPDE4APDE4CMAPK14
SCHEMBL7364684 0.81 PDE4D (0.60) PDE4BPDE4DPDE4APDE4CMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202955-A4 1,4-SUBSTITUTED 4,4-DIARYL CYCLOHEXANES SMITHKLINE BEECHAM CORP (US) 2004-02-11 EP disclosed
US-6518306-B1 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases SMITHKLINE BEECHAM CORPORATION 2003-02-11 US disclosed
EP-1202955-A2 1,4-SUBSTITUTED 4,4-DIARYL CYCLOHEXANES SmithKline Beecham Corporation (US) 2002-05-08 EP disclosed
WO-2001010385-A2 1,4-SUBSTITUTED 4,4-DIARYL CYCLOHEXANES SMITHKLINE BEECHAM CORPORATION (US) 2001-02-15 WO disclosed